Robert Wasserman
Recent Quotes
"We are initiating coverage on CVM with a Buy rating."
—
Robert Wasserman, Dawson James Securities
(3/2/15)
more >
"Malaysia was cleared for enrollment in CVM's Phase 3 clinical trial."
—
Robert Wasserman, Dawson James Securities
(2/20/15)
more >
"Investors in NEO have a lot to look forward to in the future."
—
Robert Wasserman, Dawson James Securities
(7/18/14)
more >
"OCLS has an improved balance sheet, growing revenue momentum and a solid, multinational product pipeline."
—
Robert Wasserman, Dawson James Securities
(4/10/13)
more >
"OCLS has an improved balance sheet, growing revenue momentum and a solid, multinational product pipeline."
—
Robert Wasserman, Dawson James Securities
(4/10/13)
more >
"ASTX shares have performed very well, reflecting the company's strong cash position."
—
Robert Wasserman, Dawson James Securities
(3/15/13)
more >
"ASTX has significantly increased YOY revenues."
—
Robert Wasserman, Dawson James Securities
(1/17/13)
more >
"OCLS has growing revenue momentum and a solid, multinational product pipeline."
—
Robert Wasserman, Dawson James Securities
(11/13/12)
more >
